Building Non-Communicable Eye Disease Research Capacity in India
Building Non-Communicable Eye Disease Research Capacity in India
批准号:
10491736
负责人:
DAVID C MUSCH
金额:
$22.36万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-20 至 2026-07-31
关键词:
AddressAgeAgingAmericanBlindnessCapsicumClinicalClinical ResearchClinical and Translational Science AwardsCollaborationsDementiaEducational StatusElderlyEnvironmentEpidemicEyeEye diseasesFacultyFundingGrantHomeHospitalizationIndiaInstitutionInterventionKnowledgeMental DepressionMentorsMethodsMichiganNeeds AssessmentPopulationRecording of previous eventsResearchResearch PersonnelResearch TrainingRisk FactorsRoleSensorySurveysTrainingTraining ActivityTraining ProgramsUnited States National Institutes of HealthUniversitiesVisionVisualVisual impairmentaging populationbaseblindcare systemscareerdesigndisabilityeducation researchepidemiology studyfall riskmiddle agemortalitypopulation healthprogramsskillssuccesstraining opportunityyears lived with disability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
India is home to over 17% of the world’s population and to 25% of those who are blind or visually impaired
worldwide. Blindness and vision impairment are the fourth leading cause of years lived with disability in India
and are the number one cause in those age 70 and older, a segment of the Indian population that is rapidly
growing. Over 90% of vision loss in India is due to non-communicable disease, the majority of which is
avoidable. Poor vision is associated with wide-reaching consequences, including an increased risk of falls,
dementia, depression, disability, loss of independence, longer and more frequent hospitalizations, and
increased mortality. Despite the large and growing burden of non-communicable eye disease, particularly
among older adults, the shortage of research expertise in India to characterize the epidemic and understand its
causes and consequences is a critical barrier to intervening effectively and reducing its population health
impact. Therefore, the focus of this training program is on building clinical-epidemiological research capacity,
with an emphasis on lifecourse analyses applied to the study of non-communicable eye disease (NCED) in
older adults. Given the aging of the Indian population and the disproportionate impact of NCED on older
Indians, it is critical to train Indian vision researchers in the research principles and methods that will enable
them to effectively address this critical need. Moreover, we currently lack knowledge from a lifecourse
perspective to understand the effects of early- and mid-life exposures on late-life vision and vision-related
disability in India. Research specific to the Indian context is vital to determine key risk factors and disability
consequences of NCED, and to develop effective contextualized interventions. The proposed research
capacity building program will draw upon the exceptional institutional environments at the Aravind Eye Care
System (AECS) in India and at the University of Michigan (UM), including the NIH-funded UM Claude D.
Pepper Older Americans Independence Center and Clinical and Translational Science Award. The UM and
AECS have a long-standing history of collaboration and educational exchanges. Based on the results of a
needs assessment survey, doctoral- and masters-level training tracks have been designed to meet the needs
of early- and mid-career AECS faculty who aspire to careers in clinical-epidemiological research. The aims of
this program include: 1) to provide comprehensive graduate-level training in the conduct of clinical and
epidemiologic research for trainees from AECS who will be equipped to take a leading role in NCED and
sensory aging research in India; 2) to develop the mentoring and research education skills of AECS faculty;
and 3) to establish research training opportunities at AECS that are offered to a broad regional audience. All
training activities will be transitioned to AECS by the end of the 5-year grant period. Both partner institutions
are dedicated to the success of this training program and to its strong potential to address the growing
epidemic of NCED and visual disability among India’s rapidly aging population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Building Non-Communicable Eye Disease Research Capacity in India
-
批准号:10300299
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2021
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
-
批准号:9764737
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2019
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
-
批准号:9892014
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the impact of glaucoma and its treatment on the person
-
批准号:8953499
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2015
-
负责人:DAVID C MUSCH
-
依托单位:
Assessing the impact of glaucoma and its treatment on the person
-
批准号:9124908
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2015
-
负责人:DAVID C MUSCH
-
依托单位:
Statins To Prevent Progression of Glaucoma: The STOP Glaucoma Trial
-
批准号:8445488
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2012
-
负责人:DAVID C MUSCH
-
依托单位:
Insights on Glaucoma from Analysis of the CIGTS Data
-
批准号:8289417
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:DAVID C MUSCH
-
依托单位:
Insights on Glaucoma from Analysis of the CIGTS Data
-
批准号:8111469
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2011
-
负责人:DAVID C MUSCH
-
依托单位:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
-
批准号:7532409
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2008
-
负责人:DAVID C MUSCH
-
依托单位:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
-
批准号:7675988
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2008
-
负责人:DAVID C MUSCH
-
依托单位:
Analysis of CIGTS Visual Field Data
-
批准号:6819175
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2004
-
负责人:DAVID C MUSCH
-
依托单位:
Analysis of CIGTS Visual Field Data
-
批准号:6929275
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2004
-
负责人:DAVID C MUSCH
-
依托单位:
CORNEAL ASTIGMATISM FOLLOWING PENETRATING KERATOPLASTY
-
批准号:3426368
-
项目类别:
-
资助金额:$2.24万
-
财政年份:1986
-
负责人:DAVID C MUSCH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: